Nuvve (NASDAQ:NVVE) stock is falling on Monday even after the green energy technology company announced recent insider buying.
Gregory Poilasne, cofounder of Nuvve, purchased $100,000 worth of NVVE stock at a price of 14 cents per share. That saw the cofounder increase his stake in the company by 37%.
While insider buying is typically a good thing as it shows strength in the company, this fall could be due to the purchase price. That’s because the 14 cents per share price that Poilasne paid is a decent discount compared to the prior closing price of 22 cents per share for NVVE stock.
How This Affects NVVE Stock Today
While investors don’t appear happy about this insider buying, the company’s stock isn’t seeing much activity as of Monday morning. This only has about 122,000 shares of NVVE stock changing hands as of this writing. That’s still a far way off from the company’s daily average trading volume of about 3.3 million shares.
NVVE stock is down 11.3% as of Monday morning and is also down 66.9% since the start of the year as of Friday’s close.
Investors who are looking for even more of the most recent stock market stories are going to want to stick around!
We are offering up all of the latest insight into Monday’s stock market news that traders need to know about below! A few examples include what’s happening with Conduit Pharmaceuticals (NASDAQ:CDT), Miromatrix Medical (NASDAQ:MIRO) and the biggest pre-market stock movers on Monday morning. You can catch up on that news at the following links!
More Monday Stock Market News
- Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today?
- Why Is Miromatrix Medical (MIRO) Stock Up 235% Today?
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
